The Ohio State University- James Cancer Hospital

Columbus, Ohio 43221

5 studies enrolling now · 25 studies all time

What they study most

Acute Myeloid Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Advanced Solid Tumors, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, B-Cell Lymphoma, Breast Cancer, Carcinoma, Renal Cell, Cholangiocarcinoma, Chronic Graft Versus Host Disease, Chronic Lymphocytic Leukemia, Chronic Lymphoproliferative Diseases

Studies at this site

• A Long-term Extension Study of PCI-32765 (Ibrutinib) — Recruiting now
• A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments — Recruiting now
• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study — Recruiting now
• A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer — Recruiting now
• Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia — Running, not enrolling
• Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma — Running, not enrolling
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed
• A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) — Completed
• Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Stopped early
• Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients — Completed
• A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas — Completed
• FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed
• Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive — NO_LONGER_AVAILABLE
• A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors — Stopped early
• AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma — Completed
• Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies — Stopped early
• Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study — Completed
• Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer — Completed
• Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies — Completed
• Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD) — Completed
• Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer — Completed
• Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer — Completed
• Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer — Completed